Diabetes and cancer

P Vigneri, F Frasca, L Sciacca… - Endocrine-related …, 2009 - erc.bioscientifica.com
Diabetes and cancer are two heterogeneous, multifactorial, severe, and chronic diseases.
Because of their frequency, reciprocal influences–even minor influences–may have a major …

Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease

A Belfiore, F Frasca, G Pandini, L Sciacca… - Endocrine …, 2009 - academic.oup.com
In mammals, the insulin receptor (IR) gene has acquired an additional exon, exon 11. This
exon may be skipped in a developmental and tissue-specific manner. The IR, therefore …

[HTML][HTML] Diabetes mellitus, fasting glucose, and risk of cause-specific death

Emerging Risk Factors … - New England Journal of …, 2011 - Mass Medical Soc
Background The extent to which diabetes mellitus or hyperglycemia is related to risk of
death from cancer or other nonvascular conditions is uncertain. Methods We calculated …

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

CJ Currie, CD Poole, EAM Gale - Diabetologia, 2009 - Springer
Aims/hypothesis The risk of develo** a range of solid tumours is increased in type 2
diabetes, and may be influenced by glucose-lowering therapies. We examined the risk of …

Dynamic interplay between the collagen scaffold and tumor evolution

M Egeblad, MG Rasch, VM Weaver - Current opinion in cell biology, 2010 - Elsevier
The extracellular matrix (ECM) is a key regulator of cell and tissue function. Traditionally, the
ECM has been thought of primarily as a physical scaffold that binds cells and tissues …

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

R Huxley, A Ansary-Moghaddam… - British journal of …, 2005 - nature.com
Pancreatic cancer is the eighth major form of cancer-related death worldwide, causing 227
000 deaths annually. Type-II diabetes is widely considered to be associated with pancreatic …

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

SC Larsson, N Orsini, A Wolk - Journal of the National Cancer …, 2005 - academic.oup.com
Background: Diabetes has been associated with an increased risk of colorectal cancer in
most, but not all, studies. Findings have also been inconclusive with regard to sex and …

[HTML][HTML] Hyperinsulinemia in obesity, inflammation, and cancer

AMY Zhang, EA Wellberg, JL Kopp… - … & metabolism journal, 2021 - synapse.koreamed.org
The relative insufficiency of insulin secretion and/or insulin action causes diabetes.
However, obesity and type 2 diabetes mellitus can be associated with an absolute increase …

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1–based therapies

M Elashoff, AV Matveyenko, B Gier, R Elashoff… - Gastroenterology, 2011 - Elsevier
BACKGROUND & AIMS: Glucagon-like peptide-1− based therapy is gaining widespread
use for type 2 diabetes, although there are concerns about risks for pancreatitis and …

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

SL Bowker, SR Majumdar, P Veugelers… - Diabetes …, 2006 - Am Diabetes Assoc
OBJECTIVE—Numerous studies have identified an increased risk of cancer in type 2
diabetes. We explored the association between antidiabetic therapies and cancer-related …